![Citius Pharma on X: "A multicenter Phase 3 pivotal trial is currently underway. If approved, Mino-Lok would be the first & only FDA-approved #treatment to salvage central venous catheters causing central line-related Citius Pharma on X: "A multicenter Phase 3 pivotal trial is currently underway. If approved, Mino-Lok would be the first & only FDA-approved #treatment to salvage central venous catheters causing central line-related](https://pbs.twimg.com/media/E2KYsauXEAUDrxI.jpg:large)
Citius Pharma on X: "A multicenter Phase 3 pivotal trial is currently underway. If approved, Mino-Lok would be the first & only FDA-approved #treatment to salvage central venous catheters causing central line-related
![Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD | BioBuzz Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD | BioBuzz](https://biobuzz.io/wp-content/uploads/2022/03/Vallon-Web.png)
Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD | BioBuzz
![Press Release Service: Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition - CRISPR Medicine Press Release Service: Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition - CRISPR Medicine](https://mms.businesswire.com/media/20240109040535/en/1093022/5/Vertex_Logo_colorRGB.jpg)
Press Release Service: Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition - CRISPR Medicine
![Actinium Pharmaceuticals KOL Webinar: Discussing Positive Results from the Pivotal Phase 3 SIERRA Trial of Iomab-B - LifeSci Events Actinium Pharmaceuticals KOL Webinar: Discussing Positive Results from the Pivotal Phase 3 SIERRA Trial of Iomab-B - LifeSci Events](https://lifescievents.com/wp-content/uploads/2023/01/Banners-2-1.png)
Actinium Pharmaceuticals KOL Webinar: Discussing Positive Results from the Pivotal Phase 3 SIERRA Trial of Iomab-B - LifeSci Events
![CNS Pharmaceuticals Inc.: CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM - MoneyController (ID 1106973) CNS Pharmaceuticals Inc.: CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM - MoneyController (ID 1106973)](https://www.moneycontroller.co.uk/upload/aziende/cns-pharmaceuticals-inc_20210215151047.png)
CNS Pharmaceuticals Inc.: CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM - MoneyController (ID 1106973)
![Pramiscure — Your Gateway to Success as the Best PCD in Tricity | by Pramiscure Pharmaceuticals | Medium Pramiscure — Your Gateway to Success as the Best PCD in Tricity | by Pramiscure Pharmaceuticals | Medium](https://miro.medium.com/v2/resize:fit:750/1*tKCzIZoQVVdfxaHkyqgUTA.jpeg)
Pramiscure — Your Gateway to Success as the Best PCD in Tricity | by Pramiscure Pharmaceuticals | Medium
![News - @RevivaPharma $RVPH Last Patient Evaluated in Pivotal Phase 3 RECOVER Trial for Brilaroxazine in Schizophrenia : u/DD_SUPPORT_ News - @RevivaPharma $RVPH Last Patient Evaluated in Pivotal Phase 3 RECOVER Trial for Brilaroxazine in Schizophrenia : u/DD_SUPPORT_](https://preview.redd.it/rvph-last-patient-evaluated-in-pivotal-phase-3-recover-v0-mi4c9u17csqb1.jpg?width=1200&format=pjpg&auto=webp&s=9aec1d66448cd1d7cc799bf41e2cef0585cc2c28)